<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE collection SYSTEM "BioC.dtd"><collection><source>BioC-API</source><date>20250207</date><key>collection.key</key><document><id>PMC3369921</id><infon key="license">CC BY</infon><passage><infon key="alt-title">Ecto-5â²-Nucleotidase in Endocarditis</infon><infon key="article-id_doi">10.1371/journal.pone.0038059</infon><infon key="article-id_pmc">PMC3369921</infon><infon key="article-id_pmid">22685551</infon><infon key="article-id_publisher-id">PONE-D-11-25491</infon><infon key="elocation-id">e38059</infon><infon key="issue">6</infon><infon key="license">This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</infon><infon key="name_0">surname:Fan;given-names:Jingyuan</infon><infon key="name_1">surname:Zhang;given-names:Yongshu</infon><infon key="name_2">surname:Chuang-Smith;given-names:Olivia N.</infon><infon key="name_3">surname:Frank;given-names:Kristi L.</infon><infon key="name_4">surname:Guenther;given-names:Brian D.</infon><infon key="name_5">surname:Kern;given-names:Marissa</infon><infon key="name_6">surname:Schlievert;given-names:Patrick M.</infon><infon key="name_7">surname:Herzberg;given-names:Mark C.</infon><infon key="name_8">surname:Beall;given-names:Bernard</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">7</infon><infon key="year">2012</infon><offset>0</offset><text>Ecto-5â²-Nucleotidase: A Candidate Virulence Factor in Streptococcus sanguinis Experimental Endocarditis</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>106</offset><text> Streptococcus sanguinis is the most common cause of infective endocarditis (IE). Since the molecular basis of virulence of this oral commensal bacterium remains unclear, we searched the genome of S. sanguinis for previously unidentified virulence factors. We identified a cell surface ecto-5â²-nucleotidase (Nt5e), as a candidate virulence factor. By colorimetric phosphate assay, we showed that S. sanguinis Nt5e can hydrolyze extracellular adenosine triphosphate to generate adenosine. Moreover, a nt5e deletion mutant showed significantly shorter lag time (P&lt;0.05) to onset of platelet aggregation than the wild-type strain, without affecting platelet-bacterial adhesion in vitro (Pâ=â0.98). In the absence of nt5e, S. sanguinis caused IE (4 d) in a rabbit model with significantly decreased mass of vegetations (P&lt;0.01) and recovered bacterial loads (log10CFU, Pâ=â0.01), suggesting that Nt5e contributes to the virulence of S. sanguinis in vivo. As a virulence factor, Nt5e may function by (i) hydrolyzing ATP, a pro-inflammatory molecule, and generating adenosine, an immunosuppressive molecule to inhibit phagocytic monocytes/macrophages associated with valvular vegetations. (ii) Nt5e-mediated inhibition of platelet aggregation could also delay presentation of platelet microbicidal proteins to infecting bacteria on heart valves. Both plausible Nt5e-dependent mechanisms would promote survival of infecting S. sanguinis. In conclusion, we now show for the first time that streptococcal Nt5e modulates S. sanguinis-induced platelet aggregation and may contribute to the virulence of streptococci in experimental IE.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>1741</offset><text>Introduction</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1754</offset><text> Streptococcus sanguinis, an oral commensal bacterium, is the most common cause of infective endocarditis (IE). IE is characterized by the formation of septic thrombi or vegetations on the heart valves. The development of IE involves bacterial adherence, persistence and growth. Adherence is mediated by bacterial surface molecules and host tissues. During transient bacteremia, adherent S. sanguinis attract monocytes and induce them to produce tissue factor activity and cytokines, which activate the coagulation cascade. The valve infection by S. sanguinis can also be mediated by direct interaction with platelets in the vegetation. In an animal model, S. sanguinis adherence to platelets and induction of aggregation into an in vitro thrombus correlate with the increased severity of IE. How S. sanguinis resists monocyte engulfment, platelet killing to eventually drive the formation of septic vegetations on heart valves remains unclear.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2699</offset><text>Among the agents known to modulate platelet aggregation are adenine nucleotides, which are released from platelets into the surrounding microenvironment upon stimulation with pro-thrombotic agents. Indeed, we have previously shown that dense granules containing ATP and ADP are released from platelets in response to S. sanguinis . These nucleotides can be hydrolyzed by S. sanguinis cell wall nucleotidase activity to modulate platelet aggregation. In an animal model of IE, sortase A-anchored cell surface proteins were suggested to contribute to bacterial virulence. To identify the candidate enzyme, we searched the genome of S. sanguinis SK36, and four genes containing LPxTG motifs were found that encode putative cell surface nucleotidases. The four predicted nucleotidase products would be anchored to the cell wall by a sortase A-dependent mechanism. One of them, ecto-5â²-nucleotidase (Nt5e), is a putative surface-located enzyme that could hydrolyze extracellular ATP, ADP, AMP to adenosine. Since ADP is an agonist and adenosine is a potent platelet aggregation antagonist, 5â²-nucleotidase activities on the surface of S. sanguinis may modulate S. sanguinis-induced platelet aggregation and the severity of IE.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3925</offset><text>During bacterial infection, ATP and adenosine are also important immune regulators. For example, extracellular ATP can trigger monocyte release of proinflammatory cytokines such as IL-1Î² and IL-18. In contrast, adenosine is a potent immunosuppressive molecule, which inhibits IL-12 production, and increases IL-10 in monocytes. Successful host defense balances pro- and anti-inflammatory mediators. Hence, the consumption of ATP as well as generation of adenosine by S. sanguinis Nt5e could influence the immune response during infection. We, therefore, hypothesize that Nt5e contributes to the virulence of S. sanguinis in IE.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>4556</offset><text>To identify and characterize the enzymatic activities of Nt5e, we have generated a nt5e deletion mutant (Înt5e) by allelic exchange and also complemented this strain to obtain nt5e+. We showed S. sanguinis NT5E hydrolyzes extracellular ATP to generate adenosine. Using platelet aggregation and platelet-bacterial adhesion assays, we also showed that Nt5e delayed S. sanguinis-induced human platelet aggregation without affecting platelet-bacterial adhesion. Finally, Nt5e was determined to be a plausible virulence factor in a rabbit endocarditis model.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>5114</offset><text>Results</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>5122</offset><text>Identification of the S. sanguinis Protein Possessing Cell Surface Nucleotidase Activity</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>5211</offset><text>By mining the SK36 genome, 16 putative surface proteins with LPxTG motifs were identified. Of these proteins, we identified four putative cell-surface nucleotidases based upon the presence of an LPxTG motif and substrate specificities that suggest the ability to hydrolyze a nucleotide and water to a nucleoside and orthophosphate (Table S1). Putative Nt5e showed a substrate specificity that would most likely hydrolyze released platelet adenine nucleotides and yield adenosine. To test this possibility in strain SK36, allelic exchange mutants of nt5e and the other putative nucleotidases were each constructed using primers listed in Tables S3 (SK36) and compared for loss of hydrolysis of extracellular adenine nucleotides (Figure 1). Each strain was incubated with 10, 50, or 100 ÂµM of ATP, ADP or AMP. Hydrolysis is reported as S. sanguinis Nt5e activity per cell. When strain SK36 was compared to deletion mutants of genes for the extracellular nuclease (nucH), cyclo-nucleotide phosphodiesterase (cnp) or DNA repair ATPase (rad3), only Înt5e cells lost significant ability of whole cells to hydrolyze ATP (Figure 1A, P&lt;0.05), ADP (Figure 1B, P&lt;0.05) and AMP (Figure 1C, P&lt;0.05) at each concentration examined. The ATPase, ADPase and AMPase activities of Înt5e cells were also associated with a reduction in the lag time to platelet aggregation (Figure S1).</text></passage><passage><infon key="file">pone.0038059.g001.jpg</infon><infon key="id">pone-0038059-g001</infon><infon key="section_type">FIG</infon><infon key="type">fig_title_caption</infon><offset>6588</offset><text>
nt5e confers Nt5e activity on S. sanguinis SK36 whole cells.</text></passage><passage><infon key="file">pone.0038059.g001.jpg</infon><infon key="id">pone-0038059-g001</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>6650</offset><text>Nt5e activity was measured by the release of inorganic phosphate (Pi) from adenine nucleotides. (A), (B), and (C) were showed as enzyme velocity vs. concentration of ATP, ADP and AMP substrates, where the results were represented as meanÂ±SE, nâ=â3. Statistical analysis was performed by one-way ANOVA with Dunnettâs post-test for multiple comparisons. *significantly decreased compared to wild-type strain SK36 (P&lt;0.05). Înt5e: 5â²-nucleotidase deletion mutant; ÎnucH: extracellular nuclease deletion mutant; Îcnp: cyclo-nucleotide phosphodiesterase deletion mutant; and Îrad3: DNA repair ATPase deletion mutant.</text></passage><passage><infon key="file">pone-0038059-t001.xml</infon><infon key="id">pone-0038059-t001</infon><infon key="section_type">TABLE</infon><infon key="type">table_title_caption</infon><offset>7279</offset><text>Characterization of the enzymatic activities of S. sanguinis 133-79 Nt5e.</text></passage><passage><infon key="file">pone-0038059-t001.xml</infon><infon key="id">pone-0038059-t001</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;colgroup span=&quot;1&quot;&gt;&lt;col align=&quot;left&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;center&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;center&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;center&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;center&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;center&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;center&quot; span=&quot;1&quot;/&gt;&lt;/colgroup&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Substrate&lt;/td&gt;&lt;td colspan=&quot;2&quot; align=&quot;left&quot; rowspan=&quot;1&quot;&gt;ATP&lt;/td&gt;&lt;td colspan=&quot;2&quot; align=&quot;left&quot; rowspan=&quot;1&quot;&gt;ADP&lt;/td&gt;&lt;td colspan=&quot;2&quot; align=&quot;left&quot; rowspan=&quot;1&quot;&gt;AMP&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;K&lt;sub&gt;m&lt;/sub&gt;
&lt;italic&gt;&lt;sup&gt;a&lt;/sup&gt;&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;V&lt;sub&gt;max&lt;/sub&gt;
&lt;italic&gt;&lt;sup&gt;b&lt;/sup&gt;&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;K&lt;sub&gt;m&lt;/sub&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;V&lt;sub&gt;max&lt;/sub&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;K&lt;sub&gt;m&lt;/sub&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;V&lt;sub&gt;max&lt;/sub&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;wt&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;118.0Â±35.1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;9.0Â±1.0&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;65.7Â±20.0&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5.4Â±0.5&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;38.9Â±15.6&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.0Â±0.2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Î&lt;italic&gt;nt5e&lt;/italic&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;396.0Â±25.9&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;nt103&quot;&gt;c&lt;/xref&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.7Â±0.9&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;nt103&quot;&gt;c&lt;/xref&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;italic&gt;nt5e&lt;/italic&gt;+&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;124.7Â±33.8&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;8.3Â±0.9&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;81.7Â±21.1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5.4Â±0.5&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;40.0Â±7.2&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.9Â±0.1&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>7353</offset><text>Substrate	ATP	ADP	AMP	 		Kma	Vmaxb	Km	Vmax	Km	Vmax	 	wt	118.0Â±35.1	9.0Â±1.0	65.7Â±20.0	5.4Â±0.5	38.9Â±15.6	1.0Â±0.2	 	Înt5e	396.0Â±25.9c	1.7Â±0.9c	â	â	â	â	 	nt5e+	124.7Â±33.8	8.3Â±0.9	81.7Â±21.1	5.4Â±0.5	40.0Â±7.2	0.9Â±0.1	 	</text></passage><passage><infon key="file">pone-0038059-t001.xml</infon><infon key="id">pone-0038059-t001</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>7589</offset><text>Enzyme parameters were calculated by nonlinear curve fitting using GraphPad Prism. Km was represented as mean.</text></passage><passage><infon key="file">pone-0038059-t001.xml</infon><infon key="id">pone-0038059-t001</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>7700</offset><text>Â±SE ÂµM and Vmax was represented as meanÂ±SE nmoles Pi/min per 106 cells.</text></passage><passage><infon key="file">pone-0038059-t001.xml</infon><infon key="id">pone-0038059-t001</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>7778</offset><text>Statistical analysis was performed using ANOVA, and followed by Bonferroni test. Significant differences were only. obtained when comparing wt and Înt5e, P&lt;0.01.</text></passage><passage><infon key="file">pone.0038059.g002.jpg</infon><infon key="id">pone-0038059-g002</infon><infon key="section_type">FIG</infon><infon key="type">fig_title_caption</infon><offset>7944</offset><text>Characterization of Nt5e activity on S. sanguinis 133-79 whole cells.</text></passage><passage><infon key="file">pone.0038059.g002.jpg</infon><infon key="id">pone-0038059-g002</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>8014</offset><text>Nt5e activity was measured by the release of inorganic phosphate (Pi) from adenine nucleotides. For (A), (B), and (C), the Michaelis-Menten curves were showed as enzyme velocity (represented as nmole/min/106 cells) vs. concentration of ATP, ADP and AMP substrates. (D) Effect of Nt5e inhibitor APCP on AMPase activity of S. sanguinis 133-79. The curve was fitted to a sigmoidal inhibitory dose-response curve and the inhibitory concentration 50% (IC50) value derived from the curve fit was shown. (E) Michaelis-Menten curves of AMPase activity vs. substrate concentration in the absence and presence of APCP. (F) pH dependence of AMPase activity of Nt5e. Statistical analysis was performed using non-linear regression. The results were represented as meanÂ±SE, nâ=â3; *significantly decreased compared to no inhibitor (P&lt;0.05).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>8846</offset><text>Characterization of the Enzymatic Activities of S. sanguinis 133-79 Nt5e</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>8919</offset><text>Platelets from some donors do not aggregate in response to strain SK36, reflecting donor specificity. To determine whether the enzymatic activities were expressed by other platelet-aggregating strains, we also studied S. sanguinis 133-79. Whole cells of S. sanguinis 133-79 wild-type (wt) hydrolyzed the adenine nucleotides ATP (Figure 2A), ADP (Figure 2B) and AMP (Figure 2C), following Michaelis-Menten kinetics. The Km and Vmax for the different strains tested are summarized in Table 1. Using the Înt5e strain, the ATPase activity was significantly decreased (P&lt;0.01), whereas activity in this mutant was restored to wt levels by complementation (nt5e+) (Figure 2A). In the absence of nt5e, the ADPase activity was reduced, whereas activity in this mutant was restored to wt levels by complementation (nt5e+) (Figure 2B). Similarly, AMPase activity in S. sanguinis 133-79 was fully abrogated by deletion of nt5e (Figure 2C). When complemented, nt5e+ regained AMPase activity. Indeed, Înt5e generated inorganic phosphate only with ATP as substrate, which may reflect activity of an ecto-ATPase on the cell surface of S. sanguinis as we reported. When compared to NT5E, ecto-ATPase activity did not play a major role in the hydrolysis of extracellular adenine nucleotides. Collectively, these results suggest strongly that Nt5e on S. sanguinis 133-79 hydrolyzes the adenine nucleotides ATP, ADP and AMP.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>10333</offset><text>AMPase Activity Attributed to Nt5e</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>10368</offset><text>We focused on the ability of S. sanguinis to produce adenosine, which could potentially affect the course of experimental endocarditis. Since our assays were performed with whole cells, we considered the possibility that total enzyme activity could include other phosphatases. A search of the S. sanguinis genome suggested the possible expression of two putative alkaline phosphatase (AP) ectoenzymes. To better define the enzymes responsible for whole cell AMPase activity, the assay was run in the presence of Î±,Î²-methylene ADP (APCP), a known inhibitor of Nt5e (Figures 2D and 2E). When expressed on a logarithmic scale, the APCP dose-inhibition curve was fitted to a sigmoidal, single-site model (Figure 2D), allowing determination of the half-maximal inhibitory concentration (IC50â=â8.8Â±3.8 ÂµM). In the presence of APCP (Kmâ=â66.7Â±14.1 ÂµM; Vmaxâ=â0.9Â±0.1 nmoles Pi/min per 106 cells), the whole cell AMPase activity showed an apparent increase in Km (P&lt;0.05), but no increase in the Vmax (Pâ=â0.3) compared to the no inhibitor control (Kmâ=â38.9Â±15.6 ÂµM; Vmaxâ=â1.0Â±0.2 nmoles Pi/min per 106 cells). Since the inhibition could be overcome at high concentrations of AMP substrate, APCP competitively inhibited AMPase activity (Figure 2E). Furthermore unlike Nt5e, AP is sensitive to an alkaline pH optimum. In S. sanguinis 133-79, the AMPase activity did not significantly increase with increasing pH (Figure 2F). Therefore, the AMPase activity was not AP, but attributable to Nt5e.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>11890</offset><text>Identification of Nt5e as a Cell-surface Protein from S. sanguinis </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>11958</offset><text>To show that Nt5e is a cell wall-associated enzyme, we characterized a cell surface protein fraction with the requisite enzyme activities. Recovery of the cell surface proteins fragments from S. sanguinis 133-79 was maximal after 7 minutes of TPCK-trypsin digestion (data not shown). The 7-minute tryptic digests (crude digest) of S. sanguinis 133-79 were chromatographed on a column of Sephadex G-100, pooled (Figure 3A), fractions resolved using SDS-PAGE (Figure 3B), and analyzed for platelet interactions (Table 2). Fraction 3 (G100-3) had the greatest ability to inhibit S. sanguinis-induced platelet aggregation, but had no effect on platelet-S. sanguinis adhesion (data not shown). After separation of Fraction 3 by two-dimensional SDS gel electrophoresis and analysis by mass spectrometry, two putative 5â²-nucleotidase superfamily proteins were identified (Table 3). The crude digest and fraction G100-3 showed 5â²-nucleotidase activities (Table 2). Compared with the crude digest, G100-3 had higher ATPase, ADPase and AMPase activities, which correlated with the inhibition of platelet aggregation (Table 2). In the plasma, both ADP removal and adenosine generation can inhibit platelet aggregation. Taken together, 5â²-nucleotidase is a protein cleaved from the surface of S. sanguinis 133-79, which appeared to metabolize adenine nucleotides to modulate platelet aggregation.</text></passage><passage><infon key="file">pone-0038059-t002.xml</infon><infon key="id">pone-0038059-t002</infon><infon key="section_type">TABLE</infon><infon key="type">table_title_caption</infon><offset>13349</offset><text>Recovery of Sephadex G100 fractions of S. sanguinis 133-79 tryptic digest.</text></passage><passage><infon key="file">pone-0038059-t002.xml</infon><infon key="id">pone-0038059-t002</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;colgroup span=&quot;1&quot;&gt;&lt;col align=&quot;left&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;center&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;center&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;center&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;center&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;center&quot; span=&quot;1&quot;/&gt;&lt;/colgroup&gt;&lt;thead&gt;&lt;tr&gt;&lt;td colspan=&quot;3&quot; align=&quot;left&quot; rowspan=&quot;1&quot;/&gt;&lt;td colspan=&quot;3&quot; align=&quot;left&quot; rowspan=&quot;1&quot;&gt;Hydrolysis, nmoles Pi/ng/min&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;nt105&quot;&gt;b&lt;/xref&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Fraction&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Protein, mg(recovered %)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PRP aggregationonset, min&lt;xref ref-type=&quot;table-fn&quot; rid=&quot;nt104&quot;&gt;a&lt;/xref&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;AMP&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ADP&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ATP&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;None&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7.5&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;â&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Crude digest&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6.4&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;9.8&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.15&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.12&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.11&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Fraction 1&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.3 (20.3)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7.5&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.01&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.01&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.01&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Fraction 2&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.7 (26.6)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7.8&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.12&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.10&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.09&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Fraction 3&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1.0 (15.6)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;gt;30&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.59&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.55&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.42&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Fraction 4&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.8 (12.5)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7.6&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.01&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.01&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Fraction 5&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.8 (12.5)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;7.5&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0.02&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;0&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Recovered total&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5.6 (87.5)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;/&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>13424</offset><text>	Hydrolysis, nmoles Pi/ng/minb	 	Fraction	Protein, mg(recovered %)	PRP aggregationonset, mina	AMP	ADP	ATP	 	None	â	7.5	â	â	â	 	Crude digest	6.4	9.8	0.15	0.12	0.11	 	Fraction 1	1.3 (20.3)	7.5	0.01	0.01	0.01	 	Fraction 2	1.7 (26.6)	7.8	0.12	0.10	0.09	 	Fraction 3	1.0 (15.6)	&gt;30	0.59	0.55	0.42	 	Fraction 4	0.8 (12.5)	7.6	0.01	0.01	0	 	Fraction 5	0.8 (12.5)	7.5	0.02	0	0	 	Recovered total	5.6 (87.5)					 	</text></passage><passage><infon key="file">pone-0038059-t002.xml</infon><infon key="id">pone-0038059-t002</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>13837</offset><text>PRP was preincubated with the indicated fraction at a final concentration of 0.1 mg/ml.</text></passage><passage><infon key="file">pone-0038059-t002.xml</infon><infon key="id">pone-0038059-t002</infon><infon key="section_type">TABLE</infon><infon key="type">table_footnote</infon><offset>13925</offset><text>Proteins were incubated with 50 ÂµM of AMP, ADP or ATP for 15 minutes at 37Â°C at a final concentration of 10 Âµg/ml.</text></passage><passage><infon key="file">pone.0038059.g003.jpg</infon><infon key="id">pone-0038059-g003</infon><infon key="section_type">FIG</infon><infon key="type">fig_title_caption</infon><offset>14048</offset><text>Nt5e is a trypsin-cleavable surface protein of S. sanguinis and affects platelet aggregation lag time.</text></passage><passage><infon key="file">pone.0038059.g003.jpg</infon><infon key="id">pone-0038059-g003</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>14151</offset><text>(A) Gel filtration chromatography of 7-minute tryptic digest of S. sanguinis 133-79. 6.4mg was placed on a column of Sephadex G-100 and chromatographed as described under âMaterials and methodsâ. (B) SDS-PAGE analysis of S. sanguinis tryptic digest fractions from gel filtration chromatography. All samples contained 15 Âµg of protein solubilized in 1% (w/v) SDS sample buffer. These samples were electrophoresed on a 10% gel, and stained with Coomassie Blue. Lane A, trypsin. Lane B, flow-through from void volume. Lane C, starting 7-minute crude tryptic digest. Lane D, Sephadex G-100 fraction 1. Lane E, Sephadex G-100 fraction 2. Lane F, Sephadex G-100 fraction 3. Lane G, Sephadex G-100 fraction 4. Lane H, Sephadex G-100 fraction 5. (C) PRP was stirred in an aggregometer. Wild type and Înt5e strains were added at the S. sanguinis 133-79-labeled arrowhead and aggregation was measured as increasing light transmission. The start of aggregation of each strain was indicated by arrow. The aggregation tracing in response to the nt5e+ strain (not shown) was indistinguishable from the wild type. (D) Response leading to aggregation was recorded as the mean lag-time to onset of aggregationÂ±SE, Nâ=â4; Statistical analysis was performed using one-way ANOVA with Tukey-Kramer post-test for multiple comparisons. * significantly decreased compared to wt (P&lt;0.05).</text></passage><passage><infon key="file">pone-0038059-t003.xml</infon><infon key="id">pone-0038059-t003</infon><infon key="section_type">TABLE</infon><infon key="type">table_title_caption</infon><offset>15526</offset><text>Proteins in G100-3 identified by mass spectrometry.</text></passage><passage><infon key="file">pone-0038059-t003.xml</infon><infon key="id">pone-0038059-t003</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;colgroup span=&quot;1&quot;&gt;&lt;col align=&quot;left&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;center&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;center&quot; span=&quot;1&quot;/&gt;&lt;col align=&quot;center&quot; span=&quot;1&quot;/&gt;&lt;/colgroup&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Identified protein&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Accession No.&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ID Probability&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Putative substrate specificity&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5â²-nucleotidase, putative (&lt;italic&gt;S. sanguinis&lt;/italic&gt; SK36)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;gi|125718054&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;95%&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5â²-nucleotides with preference for adenine nucleotides&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cyclo-nucleotide phosphodiesterase (&lt;italic&gt;S. sanguinis&lt;/italic&gt; SK36)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;gi|125717119&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;100%&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Nucleoside 2â²,3â²-cyclic phosphate into nucleoside 3â²-phosphate&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cyclo-nucleotide phosphodiesterase (&lt;italic&gt;S. suis&lt;/italic&gt; 98HAH33)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;gi|146321945&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;100%&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Nucleoside 2â²,3â²-cyclic phosphate into nucleoside 3â²-phosphate&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5â²-nucleotidase family protein (&lt;italic&gt;S. gordonii&lt;/italic&gt; CH1)&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;gi|157150885&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;99%&lt;/td&gt;&lt;td align=&quot;left&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;5â²-nucleotides with preference for adenine nucleotides&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>15578</offset><text>Identified protein	Accession No.	ID Probability	Putative substrate specificity	 	5â²-nucleotidase, putative (S. sanguinis SK36)	gi|125718054	95%	5â²-nucleotides with preference for adenine nucleotides	 	Cyclo-nucleotide phosphodiesterase (S. sanguinis SK36)	gi|125717119	100%	Nucleoside 2â²,3â²-cyclic phosphate into nucleoside 3â²-phosphate	 	Cyclo-nucleotide phosphodiesterase (S. suis 98HAH33)	gi|146321945	100%	Nucleoside 2â²,3â²-cyclic phosphate into nucleoside 3â²-phosphate	 	5â²-nucleotidase family protein (S. gordonii CH1)	gi|157150885	99%	5â²-nucleotides with preference for adenine nucleotides	 	</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>16197</offset><text>Inhibition of Platelet Aggregation by Nt5e</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>16240</offset><text>We next compared whole cells of S. sanguinis 133-79 wt, Înt5e and nt5e+ strains for the ability to induce platelet aggregation. In response to either wt or nt5e+, platelets from a representative donor aggregated in approximately 9 minutes (Figure 3C). The aggregation response of Înt5e showed a lag-time of approximately 5 minutes, which was significantly shorter than the wt and nt5e+ strains (Figure 3D). The magnitude of aggregation, however, was similar in response to all three strains (Figure 3C). The aggregation responses to S. sanguinis 133-79 wt, Înt5e and nt5e+ were consistent for all three platelet donors tested (data not shown). Similar results were obtained using S. sanguinis SK36 (Figure S1). Therefore, S. sanguinis Nt5e prolonged the lag time to the onset of platelet aggregation.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>17053</offset><text>Adhesion of Platelets and Bacteria</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>17088</offset><text>Since the ability to induce aggregation is a function of adhesion of S. sanguinis to platelets, we next sought to determine whether deletion of NT5E affected aggregation because adhesion was affected. The percent adhesion to platelets was similar for wt (133-79: 60.1Â±0.9%; SK36: 60.1Â±1.9%), Înt5e (133-79: 59.9Â±1.2%; SK36: 56.5Â±1.4%) and nt5e+ (133-79: 59.6Â±2.6%) strains. Hence, NT5E modulates platelet aggregation without affecting adhesion.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>17542</offset><text>Nt5e Contributes to the Virulence of S. sanguinis in Rabbit Infective Endocarditis</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>17625</offset><text>To investigate the contribution of Nt5e to S. sanguinis virulence in infective endocarditis, rabbits with experimental heart valve injury were infected by intravenous inoculation with 1Ã109 CFU S. sanguinis 133-79 wt, Înt5e, or nt5e+. Growth curves in TH broth were performed for all three strains to test for changes in cell growth or fitness. Although the nt5e deletion mutant showed a slight delay in entry to log-phase, all strains displayed similar growth rates in TH broth maintained in air with 5% CO2 (not shown). The resulting vegetations ranged from non-apparent (Figure 4A) to macroscopic lesions (Figures 4B and 4C).</text></passage><passage><infon key="file">pone.0038059.g004.jpg</infon><infon key="id">pone-0038059-g004</infon><infon key="section_type">FIG</infon><infon key="type">fig_title_caption</infon><offset>18258</offset><text>Nt5e affects vegetation weight and bacterial load in a S. sanguinis rabbit endocarditis model.</text></passage><passage><infon key="file">pone.0038059.g004.jpg</infon><infon key="id">pone-0038059-g004</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>18353</offset><text>(A) Aortic valve of a rabbit infected with S.
sanguinis 133-79 Înt5e. The aortic valve is composed of three leaflets, no visible vegetations were found and 2.5Ã103 CFUs were recovered. (B) Aortic valve of a rabbit infected with S. sanguinis 133-79 nt5e+, with one vegetation in the center leaflet (white circle) and 3.3Ã108 CFUs were recovered. (C) Aortic valve of a rabbit infected with S. sanguinis 133-79 wt, with two vegetations on center and right leaflets (white circle), respectively and 3.4Ã109 CFUs were recovered. (D) Plot of vegetation bacterial load (total CFU) versus vegetation mass. All vegetations on the aortic valve of each rabbit were pooled to obtain the vegetation weight and bacterial load (on TH plate). When no vegetations were found, the valves were scraped with a blade and plated to determine the valve bacterial load. R2â=â0.66 (nâ=â31) indicated that there is a correlation between the bacterial load and vegetation masses. (E) Bacterial loads in the rabbit endocarditis model, enumerated as log10 total CFU 4 days after infection. Statistical analysis was performed using one-way ANOVA with Tukey-Kramer post-test. Horizontal bars represent mean CFUs in each cohort.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>19562</offset><text>Four days after inoculation with S. sanguinis, bacterial load recovered from the vegetations ranged from 103 to 109 per rabbit; the vegetative masses correlated with the recovered bacterial CFUs (Figure 4D; R2â=â0.66, nâ=â31). Eight of 31 infected rabbits had no visible vegetations, which might due to insignificant injury caused by catheter placement. Total recovered bacterial CFUs indicated the relative ability of each strain to colonize and proliferate on the heart valve.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>20049</offset><text>As expected, 11 out of 12 rabbits infected with wt formed aortic vegetations with a mean mass of 18.6 mg and mean recovered bacterial load of 1.0Ã108 CFU. Similarly, after infection with nt5e+, vegetations formed in 7 of 8 rabbits with a mean mass of 12.5 mg and mean bacterial load of 0.2Ã108 CFU on TH plates, and 0.3Ã106 CFU on TH plates with appropriate antibiotics. The CFUs recovered with and without antibiotics were not significantly different. In contrast, 6 of 11 rabbits injected with Înt5e showed no vegetations. Two other rabbits died before euthanasia and were excluded from statistical analysis. In rabbits challenged with Înt5e, the mean weight of vegetations was 4.0 mg and the mean bacterial load was 0.7Ã106 CFU on non-selective and 0.1Ã106 CFU on selective plates, which were the lowest infectious loads among these three groups. Taken together, Înt5e-infected rabbits developed significantly smaller aortic vegetations (P&lt;0.01) with significantly lower bacterial CFUs (Pâ=â0.01) than rabbits challenged with the wt strain. Notably, the Înt5e group showed an approximately 100-fold reduction in mean CFUs as compared with the wt group (Figure 4E). After rescuing the nt5e gene, nt5e+ and wt infected rabbits showed comparable aortic vegetations (Pâ=â0.32) and bacterial CFUs (Pâ=â0.55).</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>21377</offset><text>Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>21388</offset><text>For the first time, we present data that strongly suggests S. sanguinis Nt5e contributes to virulence during experimental IE in rabbits. This cell surface enzyme can hydrolyze ATP to adenosine, which slows the platelet aggregation response in vitro and may reduce the accumulation of platelets on infected heart valves in vivo. As a surface protein, Nt5e could also be involved in adherence to platelets or platelet vegetations and contribute to nutrient acquisition (i.e., nucleosides) and the persistence of infection. Other than adenosine production, these explanations appear unlikely. In the presence and absence of Nt5e, adhesion of S. sanguinis to platelets is similar as we show, and growth and biofilm formation were also comparable (data not shown). It is more plausible that during IE adenosine is produced to inhibit further platelet aggregation and also function as an immunosuppressive agent. In this context, immunosuppressive adenosine has recently been implicated in other infections caused by bacteria including Staphylococcus aureus, Bacillus anthracis and also the protozoan parasite Leishmania . Since Nt5e is widely conserved, the hydrolysis of ATP to immunosuppressive adenosine in vivo may be relevant to the virulence of infection by many species. Direct evidence for the role of adenosine produced by Nt5e during infection is needed.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>22748</offset><text>As a potent immunoregulator of inflammation, adenosine inhibits the proinflammatory and promotes anti-inflammatory actions of immune cells via four specific cell surface receptors: A1, A2a, A2b, and A3 . For example, in human and mouse monocytes/macrophages, the engagement of adenosine receptors, particularly A2a receptors, by adenosine or its analogues inhibits the production of IL-12 and TNF-Î±, two proinflammatory cytokines, and increases IL-10, a protective cytokine that suppresses IL-12 and TNF-Î±.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>23263</offset><text>To understand the mechanism by which adenosine is produced, we began with our earlier observation that nucleotidase activity is expressed on the cell wall of S. sanguinis . The fact that the Nt5e deletion mutant possesses ATPase activity at higher ATP concentrations suggests a contributory role of the ecto-ATPase (higher Km) in the hydrolysis of ATP. In the present report, we distinguish the ecto-ATPase activity from Nt5e. We characterized nucleotidase activities associated with whole cells and showed that adenosine was the product of Nt5e hydrolysis of ATP, ADP or AMP in vitro. For each substrate, hydrolysis by whole cells followed Michaelis-Menten kinetics and could not be attributable to other enzyme activities associated with phosphate hydrolysis. These results and analysis of the published genome of strain SK36 and our partially sequenced strain 133-79, led us to hypothesize that the surface nucleotidase activities were attributable to a single surface enzyme, Nt5e on S. sanguinis.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>24265</offset><text>To explore the possibility that adenosine-producing activity could resolve to a single protein, Nt5e was cleaved from the cell surface of S. sanguinis 133-79 by mild trypsin digestion. When the digest was fractionated using gel filtration chromatography, Nt5e largely resolved in one of the fractions, G100-3, and its presence was confirmed by mass spectroscopic analysis. The possibility that other enzymes detected in this fraction could mimic Nt5e activity was systematically excluded. Since Nt5e can hydrolyze ATP and ADP, an agonist of platelet aggregation, and generate adenosine, an inhibitor of platelet aggregation, it was not surprising that fraction G100-3 inhibited platelet aggregation. Nt5e contains an LPxTG-motif, which is characteristic of cell wall bound surface proteins in Gram-positive bacteria. Given that enzyme activity is also expressed on intact, viable whole cells of S. sanguinis, Nt5e is an ecto-enzyme. Since the Înt5e strain was unable to hydrolyze the nucleotides to adenosine, the data strongly suggest that cell-surface Nt5e activity modulates platelet aggregation by producing adenosine from related nucleotides.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>25417</offset><text>In the absence of nt5e, the ATP and ADP released from platelet dense granules are not hydrolyzed, adenosine is not produced and the lag time to the onset of platelet aggregation is shortened. We largely ruled out that the loss of surface Înt5e affected interactions with the platelet surface since this mutant showed platelet adhesion similar to the wild-type strain. In the interactive microenvironment with platelets, S. sanguinis induces release of ATP and ADP from platelet dense granules. S. sanguinis Nt5e is, therefore, strongly suggested to hydrolyze ATP and ADP released from dense granules and produce aggregation inhibitor adenosine to modulate aggregation responses.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>26100</offset><text>In IE, the ability of S. sanguinis to induce platelet aggregation in vitro is directly related to the mass of developing thrombotic vegetations on heart valves in vivo. Using a rabbit endocarditis model, we compared the virulence of S. sanguinis 133-79 wt, Înt5e, and nt5e+ in vivo. Virulence was reflected by the weight of resulting cardiac vegetations and bacterial burden. The mass of the vegetations was directly related to the CFUs of bacteria colonizing the vegetations (R2â=â0.66, nâ=â31) when total CFUs of all strains were enumerated on non-antibiotic-containing plates. In Înt5e challenged rabbits, the mass of the vegetations and recovered bacterial CFUs were 100-fold lower than in wt infected rabbits. When complemented, nt5e+ and wt infected rabbits showed comparable aortic vegetations and bacterial CFUs on plates with no antibiotics. Based on these data, nt5e appears to be responsible for the increased virulence of the wild-type and complemented strains.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>27084</offset><text>Differences in vegetation formation and recovery of CFUs from the heart valves of infected rabbits may reflect strain-specific efficiency in bacterial clearance from heart valves. When Nt5e was expressed by infecting wt and nt5e+ strains, adenosine produced in the vegetation microenvironment could inhibit phagocytosis by infiltrating monocytes/macrophages to facilitate colonization. The concentrations of locally available adenosine would be higher than in vegetations from the Înt5e group, which showed attenuated vegetation formation and lower recovered CFUs. In addition, wt and nt5e+ strains would hydrolyze ATP in the microenvironment. Extracellular ATP, a proinflammatory signal, can be sensed by purinergic P2Y receptors, which are highly expressed on immune and non-immune cells. On endothelial cells and monocytes, stimulation with extracellular ATP leads to the release of proinflammatory cytokines such as IL-1Î² and IL-12. When ATP is hydrolyzed and adenosine is generated, proinflammatory activity would be expected to be lost and immunosuppressive activity produced. Therefore, Nt5e potentially promotes bacterial survival through ATP removal and adenosine generation. How nt5e might contribute, however, to bacteria-monocyte interactions remains to be established. We await further direct evidence for the role of Nt5e nucleotidase activities in IE; a catalytic mutant of Nt5e will be informative when developed.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>28521</offset><text>Nt5e could also play another role in the formation of vegetations in vivo. Both rabbit and human platelets release platelet microbicidal proteins (PMPs) and thrombin-inducible PMPs (tPMPs) in vitro. The PMPs and tPMPs can both kill and exert nonlethal anti-adherence effects against a wide spectrum of endovascular pathogens, including viridans streptococci. Since the Înt5e strain induced platelet aggregation faster than S. sanguinis isogenic wild-type strain, without affecting bacterial-platelet adhesion, release of PMPs would also be affected. In IE, the Înt5e strain might thwart early infection more efficiently than when nt5e is expressed. With less time for growth and doubling of the infecting bacteria, the mass of the vegetation and eventual bacterial load will be lower than in the presence of NT5E. Using two plausible mechanisms, therefore, Nt5e may contribute to the bacterial survival in the blood, persistence in the vegetation, and virulence of the organism.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>29508</offset><text>In a rabbit IE model, Turner et al. reported that a nt5e transposon mutant of S. sanguinis SK36 and the parental strain were equally competitive. These findings differed from our own. The different findings may reflect the study designs, including implementation of the animal model, the difference in the construction of the mutant, the inoculum size, and the duration of infection.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>29892</offset><text>Of note also, some rabbits developed lung congestion. During IE, formation of large aggregates of bacteria and platelets would be expected to obstruct small capillaries, such as those in the lungs. However, lung congestion did not appear to be associated with nt5e or size of vegetation (data not shown).</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>30197</offset><text>Note also that the bacterial counts from rabbits infected with Înt5e were not significantly different, based on CFUs recovered from antibiotic-containing and non-antibiotic plates. Plating efficiency was similar. For rabbits infected with nt5e+, less than 1% of the post-infection bacteria enumerated from the vegetations appeared to retain the complemented plasmid, indicating antibiotic resistance tended to be cured without the selective pressure of the specific antibiotics. The vegetation masses and bacterial CFUs recovered from non-antibiotic plates of nt5e+ and wt groups were comparable, however, suggesting that nt5e+ loses the complemented plasmid gradually during the course of infection. These results suggest that the impact of Nt5e on the persistence of S. sanguinis in the infected vegetation may be underestimated by our studies.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>31048</offset><text>In summary, we have shown that Nt5e possesses specific nucleotidase activity, which can influence platelet aggregation by the production of adenosine. Adenosine is likely to influence the outcome of Streptococcus sanguinis infection. To show that specific nucleotidase activity of Nt5e is a contributory factor towards the development of infective endocarditis, specific enzymatic activity must be mutated within the surface enzyme. In our animal model of endocarditis, we did show that Nt5e deletion attenuates virulence. We cannot completely exclude the possibility, however, that Nt5e may possess other properties that contribute towards this phenotype. Cell-surface Nt5e activities are widely distributed among bacteria including Staphylococcus aureus , Helicobacter pylori  and S. gordonii . The platelet modulating effects of Nt5e might be a common mechanism among S. sanguinis strains, and perhaps other bacterial pathogens, such as staphylococci and enterococci, which cause blood borne infections. Indeed, AMPases on pathogens like Staphylococcus epidermidis and Enterococcus faecilis can generate immunosuppressive adenosine. Therefore, the nucleotidase activity of Nt5e is suggested to be a common virulence factor for the survival of bacterial pathogens in the blood.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>32328</offset><text>Materials and Methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>32350</offset><text>Bacterial Strains and Culture Conditions</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>32391</offset><text> S. sanguinis strains were routinely grown in Todd Hewitt broth (TH broth, Difco; Sparks, MD) or on TH agar plates at 37Â°C in 5% CO2. E. coli cells were grown aerobically at 37Â°C in Luria-Bertani broth (LB broth, Bacto; Sparks, MD). When required, antibiotics were added to the medium at the indicated concentrations: erythromycin (Em), 10 Âµg mlâ1 (S. sanguinis); and kanamycin (Km), 50 Âµg mlâ1 (E. coli) or 400 Âµg mlâ1 (S. sanguinis).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>32839</offset><text>Genetic Manipulations in S. sanguinis </text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>32878</offset><text>Standard recombinant DNA techniques were employed as described. Plasmids (listed in Table S2) were purified from E. coli cells using the QIAquick Spin Miniprep purification Kit (Qiagen Inc., Valencia, CA). Oligonucleotides for strain SK36 (Table S3) and 133-79 (Table S4) were synthesized for deletion (A1 and A2) and complementation (ACom) using integrated DNA Technologies.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>33254</offset><text>Chromosomal DNA was prepared from mutanolysin-treated streptococcal cells using the Qiagen 100/G Genomic Tip system. PCR products were purified using the High Pure PCR Product Purification Kit (Roche Ltd., Indianapolis, IN). DNA restriction and modification enzymes were used according to the manufacturerâs directions (New England Biolabs Inc., Ipswich, MA).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>33616</offset><text>The target genes of S. sanguinis (wt) were inactivated by allelic exchange with the erythromycin-resistance determinant, ermAM. Briefly, ermAM was amplified from plasmid pVA891 and cloned into pPCR-Amp SK (+) (Stratagene Corp., La Jolla, CA). Two DNA fragments constituting the flanking sequences of the target genes were then amplified and fused with the ermAM genes sequentially. The fused construct was then PCR-amplified, purified and transformed into wt. For transformation, overnight cultures were grown in TH broth. The next day, cells were inoculated into fresh aliquots of the same medium (1â¶40), containing 10% heat-inactivated horse serum (Sigma-Aldrich, St. Louis, MO), and the fused DNA construct was added. Competence stimulating peptide (CSP, a gift from Dr. Jens Kreth, University of Oklahoma) was added to a final concentration of 200 ng mlâ1. Incubation continued for 5 h at 37Â°C and cells were plated on Em selective TH plates, generating the deletion mutant. The mutation was confirmed by PCR amplification and sequencing.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>34664</offset><text>To complement the deletion mutant, a DNA fragment encompassing the entire target gene and upstream promoter sequence was amplified by PCR from wt and cloned into the E. coli-streptococcal shuttle vector pDL276, generating plasmid pDL276-gene. The construct was amplified in E. coli, purified and used to transform the deletion mutant to obtain the complemented strain using the method described above.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>35066</offset><text>Nucleotidase Activities</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>35090</offset><text>Streptococcal cells in stationary phase were harvested from overnight cultures. Harvested cells were washed twice with 30 mM Trisâ¢HCl buffer (pH 7.4) containing 0.25 mM ethylenediaminetetraacetic acid (EDTA) and 30 mM sodium chloride (NaCl), followed by washing with 50 mM Trisâ¢HCl (pH 7.4) containing 130 mM sodium chloride (NaCl) and 5 mM magnesium dichloride (MgCl2), and resuspended to 2Ã109 cells per ml. For phosphate hydrolase activity, streptococcal cells were washed twice with 50 mM Trisâ¢HCl (pH 8.0) buffer containing 150 mM NaCl, 5 mM CaCl2, and 5 mM MgCl2. The bacterial suspension (0.5 ml) was mixed with AMP at final concentrations up to 100 ÂµM in a 2 ml microcentrifuge tube, or with up to 400 Âµl ADP or ATP, and incubated at 37Â°C for 30 minutes. After incubation, cells were centrifuged at 10,000Ãg for 5 minutes, and 50 Âµl of the supernatant was transferred into 96-well plates (Corning, N.Y.). Similarly, the crude tryptic digest or fractions from gel filtration (final concentration 10 Âµg/ml) were incubated with 50 ÂµM AMP, ADP or ATP at 37Â°C for 15 minutes. The reactions were stopped with an equal volume of HCl (final concentration 0.1N). The final solution (50 Âµl) was then transferred into 96-well plates. The enzymatic activity was measured as the amount of inorganic phosphate (Pi) released into the supernatants using the QuantiChrom Phosphate Assay Kit DIPI-500 (Bioassay systems, Hayward, CA). The results were expressed as nM of Pi produced/min per 106 cells or nM of Pi produced/min per ng of protein. The Km (Michaelis constant) and Vmax (maximum velocity) for AMPase activity of intact S. sanguinis cells were calculated from substrate concentration curves using nonlinear regression of four replicates for each concentration point. To minimize the likelihood that Pi was generated by other enzymes, some streptococcal cells were pretreated with 1 ÂµM to 1 mM tetramisole (Sigma-Aldrich, St. Louis, MO), an inhibitor of alkaline phosphatase, or 1 ÂµM to 1 mM adenosine 5â²-[Î±,Î²-methylene] diphosphate (APCP) (Sigma-Aldrich, St. Louis, MO), an inhibitor of mammalian Nt5e, before incubating with AMP.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>37260</offset><text>Biochemical Characterization of NT5E in Cell Wall Fractions</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>37320</offset><text>Minimal tryptic digests of S. sanguinis 133-79 were prepared as described, which leaves the cell wall intact. The crude digests representing minimally digested surface proteins were concentrated and desalted using an ultrafiltration column (10 kDa cutoff; Millipore, Billerica, MA) into 2 mL deionized water (dH2O). The salt-free protein fragment concentrates were then chromatographed on a column (1.25Ã95 cm) of Sephadex G-100 (GE Healthcare, Pittsburgh, PA) at a flow rate of 0.3 ml/min in PBS. The fraction with the greatest ability to inhibit S. sanguinis-induced platelet-rich plasma (PRP) aggregation (G100-3) was then analyzed using two-dimensional SDS gel electrophoresis. Gels were stained with silver stain and spots were excised for mass spectrometry analysis (Center for Mass Spectrometry and Proteomics, University of Minnesota).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>38165</offset><text>Platelet Aggregometry</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>38187</offset><text>Strains of S. sanguinis were tested for the ability to induce platelet aggregation using fresh PRP obtained from a single donor as described previously. A single donor was used to eliminate variability in platelet response between donors and the procedures were reviewed and approved by the IRB of the University of Minnesota. Each bacterial strain (50 Âµl suspension containing 4Ã109 cells/ml) was incubated with 450 Âµl of PRP (4Ã108 cells/ml). PRP aggregation was performed at 37Â°C with controlled stirring in a recording aggregometer (model 660, Chronolog Corp., Havertown, PA), and the lag time or delay to onset (minutes) was measured.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>38835</offset><text>Platelet Bacterial Adhesion Assay (PBAA)</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>38876</offset><text>All procedures were performed as described previously. In brief, platelets from outdated PRP (Memorial Blood Center, St. Paul, MN) were washed with PBS and fixed with 10% formalin. Washed platelets and washed streptococcal cells were incubated together or alone (controls) in microwells; the small clusters of adhering platelets and bacteria were separated from non-interacting particles by centrifugation. The sedimentation of adhering mixtures relative to controls was quantitated by the following formula: percent adhesionâ=â100Ã{1â[mixture A620 nm/(bacterium A620 nm+washed-platelet A620 nm)/2]}. Based on previous studies of the variability of the method, only adhesion scores of â¥20% were considered positive.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>39601</offset><text>Experimental Endocarditis Model</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>39633</offset><text>Injury-induced experimental endocarditis was initiated by placement of a catheter into the left side of the heart in healthy, adult New Zealand White rabbits (2 to 3 kg; obtained from Bakkom Rabbitry, Red Wing, MN), essentially as described previously. The procedures were reviewed and approved by the IACUC of the University of Minnesota. The catheter was retained in place for 2 hours to abrade the heart valve and then removed. After closure of the neck incision, viable S. sanguinis was injected intravenously via the marginal ear vein. A total of 33 rabbits were inoculated with 1Ã109 of S. sanguinis 133-79 wt (nâ=â12 rabbits), nt5e deletion mutant (Înt5e) (nâ=â13) and complemented strain (nt5e+) (nâ=â8). After four days, the animals were euthanized, hearts were removed, aortic valves were excised and vegetations were weighed. To determine infecting bacterial colony forming units (CFUs), vegetations from each rabbit were homogenized separately in 1 ml of TH broth and plated onto TH agar and CFUs were enumerated.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>40673</offset><text>To determine whether antibiotic resistance markers were lost during the four-day infection in vivo without antibiotics, samples from vegetations were also enumerated on replica plates with appropriate antibiotics. For Înt5e, the CFUs on TH plates with or without antibiotics were not significantly different (Pâ=â0.25), indicating that resistance markers were retained. In contrast, the nt5e+ group tended to show reduced growth on antibiotic-containing medium (Pâ=â0.15), suggesting loss of the complementation plasmid. Less than 1% of the bacteria enumerated from the nt5e+ group still retained the complemented plasmid.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>41305</offset><text>When vegetations were not visualized, all of the aortic valve leaflets were scraped and cultured to enumerate the bacteria colonizing the valves. Since all bacteria recovered from the aortic valve potentially contributed to the infection and vegetation formation, CFUs on TH plates without antibiotics were used for statistical analysis. All experiments were conducted under the established guidelines of the University of Minnesota Institutional Animal Care and Use Committee.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>41783</offset><text>Gene Sequences</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>41798</offset><text>We have partially sequenced the genome of S. sanguinis 133-79. The putative nt5e gene of S. sanguinis 133-79 and S. sanguinis SK36 shared 95% sequence identity. The annotated genome of S. sanguinis SK36 (NC_009009) is available at http://www.ncbi.nlm.nih.gov. The GenBank accession number for the S. sanguinis 133-79 nt5e gene is BankIt1529021 Seq1 JQ920433.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>42157</offset><text>Statistical Analysis</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>42178</offset><text>Descriptive statistics, including the means and standard errors, were calculated. Total CFUs were converted to log10 values prior to statistical analysis. Statistical analysis of data was performed using the Studentâs t-test, one-way analysis of variance (ANOVA), non-linear regression or 4-parameter logistic regression (4-PL) with GraphPad Prism 5 (GraphPad Software, La Jolla, CA). An Î±â=â0.05 was considered to be statistically significant.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title_1</infon><offset>42630</offset><text>Supporting Information</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">footnote</infon><offset>42653</offset><text>Competing Interests: The authors have declared that no competing interests exist.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">footnote</infon><offset>42735</offset><text>Funding: This project was supported by National Institutes of Health/National Institute of Dental and Craniofacial Research grants R01DE08590 (MCH) and AI074283 (PMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</text></passage><passage><infon key="section_type">REF</infon><infon key="type">title</infon><offset>43029</offset><text>References</text></passage><passage><infon key="fpage">1318</infon><infon key="lpage">1330</infon><infon key="name_0">surname:Mylonakis;given-names:E</infon><infon key="name_1">surname:Calderwood;given-names:SB</infon><infon key="section_type">REF</infon><infon key="source">J. Med</infon><infon key="type">ref</infon><infon key="volume">345</infon><infon key="year">2001</infon><offset>43040</offset><text>Infective endocarditis in adults. N. Engl.</text></passage><passage><infon key="fpage">139</infon><infon key="lpage">149</infon><infon key="name_0">surname:Moreillon;given-names:P</infon><infon key="name_1">surname:Que;given-names:Y-A</infon><infon key="pub-id_pmid">14726169</infon><infon key="section_type">REF</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><infon key="volume">363</infon><infon key="year">2004</infon><offset>43083</offset><text>Infective endocarditis.</text></passage><passage><infon key="fpage">1364</infon><infon key="lpage">1370</infon><infon key="name_0">surname:Gould;given-names:K</infon><infon key="name_1">surname:Ramirez-Ronda;given-names:CH</infon><infon key="name_2">surname:Holmes;given-names:RK</infon><infon key="name_3">surname:Sanford;given-names:JP</infon><infon key="section_type">REF</infon><infon key="source">Invest</infon><infon key="type">ref</infon><infon key="volume">56</infon><infon key="year">1975</infon><offset>43107</offset><text>Adherence of bacteria to heart valves in vitro. J. Clin.</text></passage><passage><infon key="fpage">4809</infon><infon key="lpage">4818</infon><infon key="name_0">surname:Herzberg;given-names:MC</infon><infon key="name_1">surname:MacFarlane;given-names:GD</infon><infon key="name_2">surname:Gong;given-names:K</infon><infon key="name_3">surname:Armstrong;given-names:NN</infon><infon key="name_4">surname:Witt;given-names:AR</infon><infon key="section_type">REF</infon><infon key="source">Immun</infon><infon key="type">ref</infon><infon key="volume">60</infon><infon key="year">1992</infon><offset>43164</offset><text>The platelet interactivity phenotype of Streptococcus sanguis influences the course of experimental endocarditis. Infect.</text></passage><passage><infon key="fpage">680</infon><infon key="lpage">682</infon><infon key="name_0">surname:Meyer;given-names:MW</infon><infon key="name_1">surname:Witt;given-names:AR</infon><infon key="name_2">surname:Krishnan;given-names:LK</infon><infon key="name_3">surname:Yokota;given-names:M</infon><infon key="name_4">surname:Roszkowski;given-names:MJ</infon><infon key="section_type">REF</infon><infon key="source">Haemost</infon><infon key="type">ref</infon><infon key="volume">73</infon><infon key="year">1995</infon><offset>43286</offset><text>Therapeutic advantage of recombinant human plasminogen activator in endocarditis: evidence from experiments in rabbits. Thromb.</text></passage><passage><infon key="fpage">699</infon><infon key="lpage">707</infon><infon key="name_0">surname:Yokota;given-names:M</infon><infon key="name_1">surname:Basi;given-names:DL</infon><infon key="name_2">surname:Herzberg;given-names:MC</infon><infon key="name_3">surname:Meyer;given-names:MW</infon><infon key="section_type">REF</infon><infon key="source">Immunol</infon><infon key="type">ref</infon><infon key="volume">45</infon><infon key="year">2001</infon><offset>43414</offset><text>Anti-fibrin antibody binding in valvular vegetations and kidney lesions during experimental endocarditis. Microbiol.</text></passage><passage><infon key="fpage">1227</infon><infon key="lpage">1234</infon><infon key="name_0">surname:Ruggeri;given-names:ZM</infon><infon key="section_type">REF</infon><infon key="source">Med</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2002</infon><offset>43531</offset><text>Platelets in atherothrombosis. Nat.</text></passage><passage><infon key="fpage">435</infon><infon key="lpage">442</infon><infon key="name_0">surname:Herzberg;given-names:MC</infon><infon key="name_1">surname:Krishnan;given-names:LK</infon><infon key="name_2">surname:MacFarlane;given-names:GD</infon><infon key="section_type">REF</infon><infon key="source">Med</infon><infon key="type">ref</infon><infon key="volume">4</infon><infon key="year">1993</infon><offset>43567</offset><text>Involvement of alpha 2-adrenoreceptors and G proteins in the modulation of platelet secretion in response to Streptococcus sanguis. Crit. Rev. Oral Biol.</text></passage><passage><infon key="fpage">180</infon><infon key="lpage">185</infon><infon key="name_0">surname:MacFarlane;given-names:GD</infon><infon key="name_1">surname:Sampson;given-names:DE</infon><infon key="name_2">surname:Clawson;given-names:DJ</infon><infon key="name_3">surname:Clawson;given-names:CC</infon><infon key="name_4">surname:Kelly;given-names:KL</infon><infon key="section_type">REF</infon><infon key="source">Immunol</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">1994</infon><offset>43721</offset><text>Evidence for an ecto-ATPase on the cell wall of Streptococcus sanguis. Oral Microbiol.</text></passage><passage><infon key="fpage">120</infon><infon key="lpage">125</infon><infon key="name_0">surname:Herzberg;given-names:MC</infon><infon key="name_1">surname:Brintzenhofe;given-names:KL</infon><infon key="section_type">REF</infon><infon key="source">Immun</infon><infon key="type">ref</infon><infon key="volume">40</infon><infon key="year">1983</infon><offset>43808</offset><text>ADP-like platelet aggregation activity generated by viridans streptococci incubated with exogenous ATP. Infect.</text></passage><passage><infon key="fpage">480</infon><infon key="lpage">486</infon><infon key="name_0">surname:Weiss;given-names:WJ</infon><infon key="name_1">surname:Lenoy;given-names:E</infon><infon key="name_2">surname:Murphy;given-names:T</infon><infon key="name_3">surname:Tardio;given-names:L</infon><infon key="name_4">surname:Burgio;given-names:P</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="volume">53</infon><infon key="year">2004</infon><offset>43920</offset><text>Effect of srtA and srtB gene expression on the virulence of Staphylococcus aureus in animal models of infection. J. Antimicrob. Chemother.</text></passage><passage><infon key="fpage">4966</infon><infon key="lpage">4975</infon><infon key="name_0">surname:Turner;given-names:LS</infon><infon key="name_1">surname:Kanamoto;given-names:T</infon><infon key="name_2">surname:Unoki;given-names:T</infon><infon key="name_3">surname:Munro;given-names:CL</infon><infon key="name_4">surname:Wu;given-names:H</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="volume">77</infon><infon key="year">2009</infon><offset>44059</offset><text>Comprehensive evaluation of Streptococcus sanguinis cell wall-anchored proteins in early infective endocarditis. Infect. Immun.</text></passage><passage><infon key="fpage">3166</infon><infon key="lpage">3175</infon><infon key="name_0">surname:Xu;given-names:P</infon><infon key="name_1">surname:Alves;given-names:JM</infon><infon key="name_2">surname:Kitten;given-names:T</infon><infon key="name_3">surname:Brown;given-names:A</infon><infon key="name_4">surname:Chen;given-names:Z</infon><infon key="pub-id_pmid">17277061</infon><infon key="section_type">REF</infon><infon key="source">J. Bacteriol</infon><infon key="type">ref</infon><infon key="volume">189</infon><infon key="year">2007</infon><offset>44187</offset><text>Genome of the opportunistic pathogen Streptococcus sanguinis.</text></passage><passage><infon key="fpage">5013</infon><infon key="lpage">5015</infon><infon key="name_0">surname:Cossart;given-names:P</infon><infon key="name_1">surname:JonquiÃ¨res;given-names:R</infon><infon key="section_type">REF</infon><infon key="source">U.S.A</infon><infon key="type">ref</infon><infon key="volume">97</infon><infon key="year">2000</infon><offset>44249</offset><text>Sortase, a universal target for therapeutic agents against gram-positive bacteria? Proc. Natl. Acad. Sci.</text></passage><passage><infon key="fpage">345</infon><infon key="lpage">365</infon><infon key="name_0">surname:Zimmermann;given-names:H</infon><infon key="section_type">REF</infon><infon key="source">J 285 (Pt</infon><infon key="type">ref</infon><infon key="volume">2)</infon><infon key="year">1992</infon><offset>44355</offset><text>5â²-Nucleotidase: molecular structure and functional aspects. Biochem.</text></passage><passage><infon key="fpage">1503</infon><infon key="lpage">1505</infon><infon key="name_0">surname:Woulfe;given-names:D</infon><infon key="name_1">surname:Yang;given-names:J</infon><infon key="name_2">surname:Brass;given-names:L</infon><infon key="section_type">REF</infon><infon key="source">Invest</infon><infon key="type">ref</infon><infon key="volume">107</infon><infon key="year">2001</infon><offset>44427</offset><text>ADP and platelets: the end of the beginning. J. Clin.</text></passage><passage><infon key="fpage">1720</infon><infon key="lpage">1726</infon><infon key="name_0">surname:Cristalli;given-names:G</infon><infon key="name_1">surname:Volpini;given-names:R</infon><infon key="name_2">surname:Vittori;given-names:S</infon><infon key="name_3">surname:Camaioni;given-names:E</infon><infon key="name_4">surname:Monopoli;given-names:A</infon><infon key="section_type">REF</infon><infon key="source">Chem</infon><infon key="type">ref</infon><infon key="volume">37</infon><infon key="year">1994</infon><offset>44481</offset><text>2-Alkynyl derivatives of adenosine-5â²-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation. J. Med.</text></passage><passage><infon key="fpage">8067</infon><infon key="lpage">8072</infon><infon key="name_0">surname:Piccini;given-names:A</infon><infon key="name_1">surname:Carta;given-names:S</infon><infon key="name_2">surname:Tassi;given-names:S</infon><infon key="name_3">surname:LasigliÃ©;given-names:D</infon><infon key="name_4">surname:Fossati;given-names:G</infon><infon key="section_type">REF</infon><infon key="source">U.S.A</infon><infon key="type">ref</infon><infon key="volume">105</infon><infon key="year">2008</infon><offset>44645</offset><text>ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1Î² and IL-18 secretion in an autocrine way. Proc. Natl. Acad. Sci.</text></passage><passage><infon key="fpage">4408</infon><infon key="lpage">4414</infon><infon key="name_0">surname:Le Moine;given-names:O</infon><infon key="name_1">surname:Stordeur;given-names:P</infon><infon key="name_2">surname:Schandene;given-names:L</infon><infon key="name_3">surname:Marchant;given-names:A</infon><infon key="name_4">surname:de Groote;given-names:D</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="volume">156</infon><infon key="year">1996</infon><offset>44809</offset><text>Adenosine enhances IL-10 secretion by human monocytes. J. Immunol.</text></passage><passage><infon key="fpage">436</infon><infon key="lpage">442</infon><infon key="name_0">surname:Link;given-names:AA</infon><infon key="name_1">surname:Kino;given-names:T</infon><infon key="name_2">surname:Worth;given-names:JA</infon><infon key="name_3">surname:McGuire;given-names:JL</infon><infon key="name_4">surname:Crane;given-names:ML</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="volume">164</infon><infon key="year">2000</infon><offset>44876</offset><text>Ligand-Activation of the adenosine A2a receptors Inhibits IL-12 production by human monocytes. J. Immunol.</text></passage><passage><infon key="fpage">222</infon><infon key="lpage">225</infon><infon key="name_0">surname:Soberay;given-names:AH</infon><infon key="name_1">surname:Herzberg;given-names:MC</infon><infon key="name_2">surname:Rudney;given-names:JD</infon><infon key="name_3">surname:Nieuwenhuis;given-names:HK</infon><infon key="name_4">surname:Sixma;given-names:JJ</infon><infon key="section_type">REF</infon><infon key="source">Haemost</infon><infon key="type">ref</infon><infon key="volume">57</infon><infon key="year">1987</infon><offset>44983</offset><text>Responses of platelets to strains of Streptococcus sanguis: findings in healthy subjects, Bernard-Soulier, Glanzmannâs, and collagen-unresponsive patients. Thromb.</text></passage><passage><infon key="fpage">2157</infon><infon key="lpage">2162</infon><infon key="name_0">surname:Kawashima;given-names:Y</infon><infon key="name_1">surname:Nagasawa;given-names:T</infon><infon key="name_2">surname:Ninomiya;given-names:H</infon><infon key="pub-id_pmid">10979961</infon><infon key="section_type">REF</infon><infon key="source">Blood</infon><infon key="type">ref</infon><infon key="volume">96</infon><infon key="year">2000</infon><offset>45149</offset><text>Contribution of ecto-5â²-nucleotidase to the inhibition of platelet aggregation by human endothelial cells.</text></passage><passage><infon key="fpage">470</infon><infon key="lpage">483</infon><infon key="name_0">surname:Garen;given-names:A</infon><infon key="name_1">surname:Levinthal;given-names:C</infon><infon key="section_type">REF</infon><infon key="source">Acta</infon><infon key="type">ref</infon><infon key="volume">38</infon><infon key="year">1960</infon><offset>45258</offset><text>A fine-structure genetic and chemical study of the enzyme alkaline phosphatase of E. coli. I. Purification and characterization of alkaline phosphatase. Biochim. Biophys.</text></passage><passage><infon key="fpage">416</infon><infon key="lpage">422</infon><infon key="name_0">surname:IyÃº;given-names:D</infon><infon key="name_1">surname:Glenn;given-names:JR</infon><infon key="name_2">surname:White;given-names:AE</infon><infon key="name_3">surname:Fox;given-names:SC</infon><infon key="name_4">surname:Heptinstall;given-names:S</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="volume">31</infon><infon key="year">2011</infon><offset>45429</offset><text>Adenosine derived from ADP can contribute to inhibition of platelet aggregation in the presence of a P2Y12 antagonist. Arterioscler. Thromb. Vasc. Biol.</text></passage><passage><infon key="fpage">1457</infon><infon key="lpage">1469</infon><infon key="name_0">surname:Herzberg;given-names:MC</infon><infon key="name_1">surname:Brintzenhofe;given-names:KL</infon><infon key="name_2">surname:Clawson;given-names:CC</infon><infon key="section_type">REF</infon><infon key="source">Immun</infon><infon key="type">ref</infon><infon key="volume">39</infon><infon key="year">1983</infon><offset>45582</offset><text>Aggregation of human platelets and adhesion of Streptococcus sanguis. Infect.</text></passage><passage><infon key="fpage">16</infon><infon key="lpage">24</infon><infon key="name_0">surname:BerrÃªdo-Pinho;given-names:M</infon><infon key="name_1">surname:Peres-Sampaio;given-names:CE</infon><infon key="name_2">surname:Chrispim;given-names:PP</infon><infon key="name_3">surname:Belmont-Firpo;given-names:R</infon><infon key="name_4">surname:Lemos;given-names:AP</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="volume">391</infon><infon key="year">2001</infon><offset>45660</offset><text>A Mg-dependent ecto-ATPase in Leishmania amazonensis and its possible role in adenosine acquisition and virulence. Arch. Biochem. Biophys.</text></passage><passage><infon key="fpage">16</infon><infon key="lpage">25</infon><infon key="name_0">surname:Pinheiro;given-names:CM</infon><infon key="name_1">surname:Martins-Duarte;given-names:ES</infon><infon key="name_2">surname:Ferraro;given-names:RB</infon><infon key="name_3">surname:Fonseca de Souza;given-names:AL</infon><infon key="name_4">surname:Gomes;given-names:MT</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="volume">114</infon><infon key="year">2006</infon><offset>45799</offset><text> Leishmania amazonensis: Biological and biochemical characterization of ecto-nucleoside triphosphate diphosphohydrolase activities. Exp. Parasitol.</text></passage><passage><infon key="fpage">2417</infon><infon key="lpage">2427</infon><infon key="name_0">surname:Thammavongsa;given-names:V</infon><infon key="name_1">surname:Kern;given-names:JW</infon><infon key="name_2">surname:Missiakas;given-names:DM</infon><infon key="name_3">surname:Schneewind;given-names:O</infon><infon key="section_type">REF</infon><infon key="source">Med</infon><infon key="type">ref</infon><infon key="volume">206</infon><infon key="year">2009</infon><offset>45947</offset><text> Staphylococcus aureus synthesizes adenosine to escape host immune responses. J. Exp.</text></passage><passage><infon key="fpage">447</infon><infon key="lpage">455</infon><infon key="name_0">surname:HaskÃ³;given-names:G</infon><infon key="name_1">surname:Pacher;given-names:P</infon><infon key="section_type">REF</infon><infon key="source">Biol</infon><infon key="type">ref</infon><infon key="volume">83</infon><infon key="year">2008</infon><offset>46033</offset><text>A2A receptors in inflammation and injury: lessons learned from transgenic animals. J. Leukoc.</text></passage><passage><infon key="fpage">4634</infon><infon key="lpage">4640</infon><infon key="name_0">surname:HaskÃ³;given-names:G</infon><infon key="name_1">surname:SzabÃ³;given-names:C</infon><infon key="name_2">surname:NÃ©meth;given-names:ZH</infon><infon key="name_3">surname:Kvetan;given-names:V</infon><infon key="name_4">surname:Pastores;given-names:SM</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="volume">157</infon><infon key="year">1996</infon><offset>46127</offset><text>Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J. Immunol.</text></passage><passage><infon key="fpage">2065</infon><infon key="lpage">2074</infon><infon key="name_0">surname:HaskÃ³;given-names:G</infon><infon key="name_1">surname:Kuhel;given-names:DG</infon><infon key="name_2">surname:Chen;given-names:JF</infon><infon key="name_3">surname:Schwarzschild;given-names:MA</infon><infon key="name_4">surname:Deitch;given-names:EA</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">2000</infon><offset>46287</offset><text>Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J.</text></passage><passage><infon key="fpage">4026</infon><infon key="lpage">4032</infon><infon key="name_0">surname:Khoa;given-names:ND</infon><infon key="name_1">surname:Montesinos;given-names:MC</infon><infon key="name_2">surname:Reiss;given-names:AB</infon><infon key="name_3">surname:Delano;given-names:D</infon><infon key="name_4">surname:Awadallah;given-names:N</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="volume">167</infon><infon key="year">2001</infon><offset>46413</offset><text>Inflammatory cytokines regulate function and expression of adenosine A(2A) receptors in human monocytic THP-1 cells. J. Immunol.</text></passage><passage><infon key="fpage">5906</infon><infon key="lpage">5914</infon><infon key="name_0">surname:Meyer;given-names:MW</infon><infon key="name_1">surname:Gong;given-names:K</infon><infon key="name_2">surname:Herzberg;given-names:MC</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="volume">66</infon><infon key="year">1998</infon><offset>46542</offset><text> Streptococcus sanguis-induced platelet clotting in rabbits and hemodynamic and cardiopulmonary consequences. Infect. Immun.</text></passage><passage><infon key="fpage">218</infon><infon key="lpage">223</infon><infon key="name_0">surname:Schlievert;given-names:PM</infon><infon key="name_1">surname:Gahr;given-names:PJ</infon><infon key="name_2">surname:Assimacopoulos;given-names:AP</infon><infon key="name_3">surname:Dinges;given-names:MM</infon><infon key="name_4">surname:Stoehr;given-names:JA</infon><infon key="section_type">REF</infon><infon key="source">Immun</infon><infon key="type">ref</infon><infon key="volume">66</infon><infon key="year">1998</infon><offset>46667</offset><text>Aggregation and binding substances enhance pathogenicity in rabbit models of Enterococcus faecalis endocarditis. Infect.</text></passage><passage><infon key="fpage">4818</infon><infon key="lpage">4821</infon><infon key="name_0">surname:Veltrop;given-names:MHAM</infon><infon key="name_1">surname:Bancsi;given-names:MJLMF</infon><infon key="name_2">surname:Bertina;given-names:RM</infon><infon key="name_3">surname:Thompson;given-names:J</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="volume">68</infon><infon key="year">2000</infon><offset>46788</offset><text>Role of monocytes in experimental Staphylococcus aureus endocarditis. Infect. Immun.</text></passage><passage><infon key="fpage">587</infon><infon key="lpage">600</infon><infon key="name_0">surname:Di Virgilio;given-names:F</infon><infon key="name_1">surname:Chiozzi;given-names:P</infon><infon key="name_2">surname:Ferrari;given-names:D</infon><infon key="name_3">surname:Falzoni;given-names:S</infon><infon key="name_4">surname:Sanz;given-names:JM</infon><infon key="pub-id_pmid">11157473</infon><infon key="section_type">REF</infon><infon key="source">Blood</infon><infon key="type">ref</infon><infon key="volume">97</infon><infon key="year">2001</infon><offset>46873</offset><text>Nucleotide receptors: an emerging family of regulatory molecules in blood cells.</text></passage><passage><infon key="fpage">272</infon><infon key="lpage">278</infon><infon key="name_0">surname:Imai;given-names:M</infon><infon key="name_1">surname:Goepfert;given-names:C</infon><infon key="name_2">surname:Kaczmarek;given-names:E</infon><infon key="name_3">surname:Robson;given-names:SC</infon><infon key="section_type">REF</infon><infon key="source">Commun</infon><infon key="type">ref</infon><infon key="volume">270</infon><infon key="year">2000</infon><offset>46954</offset><text>CD39 modulates IL-1 release from activated endothelial cells. Biochem. Biophys. Res.</text></passage><passage><infon key="fpage">1023</infon><infon key="lpage">1031</infon><infon key="name_0">surname:Yeaman;given-names:MR</infon><infon key="name_1">surname:Tang;given-names:YQ</infon><infon key="name_2">surname:Shen;given-names:AJ</infon><infon key="name_3">surname:Bayer;given-names:AS</infon><infon key="name_4">surname:Selsted;given-names:ME</infon><infon key="section_type">REF</infon><infon key="source">Immun</infon><infon key="type">ref</infon><infon key="volume">65</infon><infon key="year">1997</infon><offset>47039</offset><text>Purification and in vitro activities of rabbit platelet microbicidal proteins. Infect.</text></passage><passage><infon key="fpage">116</infon><infon key="lpage">126</infon><infon key="name_0">surname:Yeaman;given-names:MR</infon><infon key="name_1">surname:Bayer;given-names:AS</infon><infon key="section_type">REF</infon><infon key="source">Updat</infon><infon key="type">ref</infon><infon key="volume">2</infon><infon key="year">1999</infon><offset>47126</offset><text>Antimicrobial peptides from platelets. Drug Resist.</text></passage><passage><infon key="name_0">surname:Yeaman;given-names:MR</infon><infon key="section_type">REF</infon><infon key="source">Dis 25: 951â968; quiz 969â970</infon><infon key="type">ref</infon><infon key="year">1997</infon><offset>47178</offset><text>The role of platelets in antimicrobial host defense. Clin. Infect.</text></passage><passage><infon key="fpage">3416</infon><infon key="lpage">3423</infon><infon key="name_0">surname:Yeaman;given-names:MR</infon><infon key="name_1">surname:Sullam;given-names:PM</infon><infon key="name_2">surname:Dazin;given-names:PF</infon><infon key="name_3">surname:Bayer;given-names:AS</infon><infon key="section_type">REF</infon><infon key="source">Immun</infon><infon key="type">ref</infon><infon key="volume">62</infon><infon key="year">1994</infon><offset>47245</offset><text>Platelet microbicidal protein alone and in combination with antibiotics reduces Staphylococcus aureus adherence to platelets in vitro. Infect.</text></passage><passage><infon key="fpage">56</infon><infon key="name_0">surname:Thammavongsa;given-names:V</infon><infon key="name_1">surname:Schneewind;given-names:O</infon><infon key="name_2">surname:Missiakas;given-names:DM</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">2011</infon><offset>47388</offset><text>Enzymatic properties of Staphylococcus aureus adenosine synthase (AdsA). BMC Biochem.</text></passage><passage><infon key="fpage">483</infon><infon key="lpage">493</infon><infon key="name_0">surname:Ki;given-names:MR</infon><infon key="name_1">surname:Yun;given-names:SK</infon><infon key="name_2">surname:Choi;given-names:KM</infon><infon key="name_3">surname:Hwang;given-names:SY</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="volume">21</infon><infon key="year">2011</infon><offset>47474</offset><text>Identification and characterization of the acid phosphatase HppA in Helicobacter pylori. J. Microbiol. Biotechnol.</text></passage><passage><infon key="fpage">1977</infon><infon key="lpage">1988</infon><infon key="name_0">surname:Davies;given-names:JR</infon><infon key="name_1">surname:SvensÃ¤ter;given-names:G</infon><infon key="name_2">surname:Herzberg;given-names:MC</infon><infon key="pub-id_pmid">19383683</infon><infon key="section_type">REF</infon><infon key="source">Microbiology</infon><infon key="type">ref</infon><infon key="volume">155</infon><infon key="year">2009</infon><offset>47589</offset><text>Identification of novel LPXTG-linked surface proteins from Streptococcus gordonii.</text></passage><passage><infon key="fpage">3489</infon><infon key="lpage">3494</infon><infon key="name_0">surname:Zhang;given-names:Y</infon><infon key="name_1">surname:Lei;given-names:Y</infon><infon key="name_2">surname:Khammanivong;given-names:A</infon><infon key="name_3">surname:Herzberg;given-names:MC</infon><infon key="section_type">REF</infon><infon key="source">Immun</infon><infon key="type">ref</infon><infon key="volume">72</infon><infon key="year">2004</infon><offset>47672</offset><text>Identification of a novel two-component system in Streptococcus gordonii V288 involved in biofilm formation. Infect.</text></passage><passage><infon key="fpage">145</infon><infon key="lpage">150</infon><infon key="name_0">surname:Macrina;given-names:FL</infon><infon key="name_1">surname:Evans;given-names:RP</infon><infon key="name_2">surname:Tobian;given-names:JA</infon><infon key="name_3">surname:Hartley;given-names:DL</infon><infon key="name_4">surname:Clewell;given-names:DB</infon><infon key="pub-id_pmid">6319229</infon><infon key="section_type">REF</infon><infon key="source">Gene</infon><infon key="type">ref</infon><infon key="volume">25</infon><infon key="year">1983</infon><offset>47789</offset><text>Novel shuttle plasmid vehicles for Escherichia-Streptococcus transgeneric cloning.</text></passage><passage><infon key="fpage">3106</infon><infon key="lpage">3114</infon><infon key="name_0">surname:Nobbs;given-names:AH</infon><infon key="name_1">surname:Zhang;given-names:Y</infon><infon key="name_2">surname:Khammanivong;given-names:A</infon><infon key="name_3">surname:Herzberg;given-names:MC</infon><infon key="pub-id_pmid">17277052</infon><infon key="section_type">REF</infon><infon key="source">J. Bacteriol</infon><infon key="type">ref</infon><infon key="volume">189</infon><infon key="year">2007</infon><offset>47872</offset><text> Streptococcus gordonii Hsa environmentally constrains competitive binding by Streptococcus sanguinis to saliva-coated hydroxyapatite.</text></passage><passage><infon key="fpage">1194</infon><infon key="lpage">1201</infon><infon key="name_0">surname:Dunny;given-names:GM</infon><infon key="name_1">surname:Lee;given-names:LN</infon><infon key="name_2">surname:LeBlanc;given-names:DJ</infon><infon key="section_type">REF</infon><infon key="source">Microbiol</infon><infon key="type">ref</infon><infon key="volume">57</infon><infon key="year">1991</infon><offset>48007</offset><text>Improved electroporation and cloning vector system for gram-positive bacteria. Appl. Environ.</text></passage><passage><infon key="fpage">14080</infon><infon key="lpage">14087</infon><infon key="name_0">surname:Erickson;given-names:PR</infon><infon key="name_1">surname:Herzberg;given-names:MC</infon><infon key="section_type">REF</infon><infon key="source">Chem</infon><infon key="type">ref</infon><infon key="volume">265</infon><infon key="year">1990</infon><offset>48101</offset><text>Purification and partial characterization of a 65-kDa platelet aggregation-associated protein antigen from the surface of Streptococcus sanguis. J. Biol.</text></passage><passage><infon key="fpage">515</infon><infon key="lpage">522</infon><infon key="name_0">surname:Herzberg;given-names:MC</infon><infon key="name_1">surname:Gong;given-names:K</infon><infon key="name_2">surname:MacFarlane;given-names:GD</infon><infon key="name_3">surname:Erickson;given-names:PR</infon><infon key="name_4">surname:Soberay;given-names:AH</infon><infon key="section_type">REF</infon><infon key="source">Immun</infon><infon key="type">ref</infon><infon key="volume">58</infon><infon key="year">1990</infon><offset>48255</offset><text>Phenotypic characterization of Streptococcus sanguis virulence factors associated with bacterial endocarditis. Infect.</text></passage><passage><infon key="fpage">471</infon><infon key="lpage">484</infon><infon key="name_0">surname:Kilian;given-names:M</infon><infon key="name_1">surname:Mikkelsen;given-names:L</infon><infon key="name_2">surname:Henrichsen;given-names:J</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="volume">39</infon><infon key="year">1989</infon><offset>48374</offset><text>Taxonomic Study of Viridans Streptococci: Description of Streptococcus gordonii sp. nov. and emended descriptions of Streptococcus sanguis (White and Niven 1946), Streptococcus oralis (Bridge and Sneath 1982), and Streptococcus mitis (Andrewes and Horder 1906). Int. J. Syst. Bacteriol.</text></passage></document>
</collection>